NDC11 68982026101
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 68982-0261-01 | 68982-0261 |
| 68982-0261-1 | 68982-0261 |
| 68982-261-01 | 68982-261 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Balfaxar | PROTHROMBIN COMPLEX CONCENTRATE (HUMAN) | Octapharma USA Inc | 68fa4f90-8b01-6498-4140-e0be5247c3fe | 2023-07-21 | Boxed warning, Warnings, Adverse reactions | 68982-261-01 68982-261 68982026101 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.